Navigation Links
Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness

IRVING, Texas, March 23 /PRNewswire/ -- Usability Sciences Corporation launches its WebIQ Pharma offering, an intelligent survey solution that provides pharmaceutical sites with metrics to answer critical questions about site and content effectiveness, to increase return on investment (ROI).  Usability Sciences has provided usability and user experience research to Merck (MRK), Eli Lilly (LLY), Novartis (NVS) and Ortho McNeil for over ten years.

Pharmaceutical brands build websites primarily to drive drug adoption. The brands want site visitors who have never tried the drug to make appointments with their doctors to discuss the drug. The brands want visitors who have been prescribed the drug to keep taking it and get their prescriptions refilled. Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do not.  Establishing the link between visitor response to the site and the content that determined their response has heretofore been extremely difficult. WebIQ Pharma makes it simple and, compared to the labor-intensive alternatives, extremely cost effective.

"WebIQ Pharma employs intelligent survey technology and intelligent dashboards in delivering this patented solution," said Usability Sciences President Jeff Schueler. "The intelligent survey technology allows the brand to ask questions of site visitors based on where they went on the site and what content they saw. WebIQ Pharma dashboards, rather than deliver more 'dumb' data, provide answers to the site's key business questions."

Usability Sciences developed the methodology specifically for the pharmaceutical industry, where brand sites often carry high costs but generate relatively low traffic. WebIQ Pharma arms the brand with a continuous stream of answers to drug adoption questions and allows them to constantly improve site stickiness, conversion, and ROI. WebIQ Pharma is flexible and can be customized to fit any brand's needs and preferences in terms of options and pricing.

More information can be found at or by contacting the company directly at

About Usability Sciences:

With more than 20 years of experience in the usability and user experience arena, Usability Sciences has developed an industry-leading portfolio of research methodologies that delivers robust and actionable results to its Fortune 500 client base. For more information about Usability Sciences' service offerings, go to or call 1-800-820-1222.

    Press Release Contact Information:
    Jeff Schueler
    Media Liaison
    Usability Sciences Corporation
    (972) 550-1599

This release was issued through WebWire(R). For more information visit

SOURCE Usability Sciences Corporation

Back to top



SOURCE Usability Sciences Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
2. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
5. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
6. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
7. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
8. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
9. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Alfacell Corporation to Present at UBS Global Life Sciences Conference
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  PTS Diagnostics, the U.S.-based manufacturer ... analyzers, A1CNow ® systems, and PTS Detect™ ... of patents that will propel the company into the ... Europe . The technology is a ... those on smartphones and tablets, and uses test strip ...
(Date:11/30/2015)... , Nov. 30, 2015 Oramed Pharmaceuticals ... focused on the development of oral drug delivery systems, ... agreements valued at up to $50,000,000 with Hefei Tianhui Incubator of Technologies ... oral insulin capsule, ORMD-0801, in China ... Macau . The agreements were signed at ...
(Date:11/30/2015)... , Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), today ... live at on December 3, 2015. TIME: ... TIME: 3:15p.m. ET LINK: --> ... --> ... where investors are invited to ask the company questions in ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... The recently published 32nd ... System (NPDS) reveals that in 2014, someone called a poison center about every ... of which were human exposure cases. , The American Association of Poison Control ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... promoting breast and prostate cancer education and prevention—is joining forces with the award-winning ... philanthropy and Hollywood elegance on December 7, 2015 at the Union League of ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... Reports magazine, quoted Michael Hansen, Ph.D., a senior scientist at Consumer Reports as ... more so for a child’s exposure limits. , The original Nov 2015 CR ...
(Date:11/30/2015)... ... November 30, 2015 , ... An inventor from Charlottesville, Va., ... womb. "My last baby had high blood pressure due to loud noises," she said, ... their babies from noise pollution as well as radio waves and microwaves." , The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... automated breast density assessment and enterprise analytics solutions, here at the 101st ... (South Hall booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements ...
Breaking Medicine News(10 mins):